Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
07:00:02 08/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 85.78 USD | -0.81% |
|
-2.61% | +0.62% |
| Market Cap | 49.85B 44.54B 41.55B 37.74B 71.08B 4,822B 71.62B 499B 195B 2,452B 187B 183B 7,884B | P/E 2026 * |
34.8x | P/E 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise Value | 46.22B 41.29B 38.53B 34.99B 65.91B 4,471B 66.4B 463B 181B 2,274B 174B 170B 7,309B | EV / Sales 2026 * |
6.83x | EV / Sales 2027 * | 6.01x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.81% | ||
| 1 week | -2.61% | ||
| Current month | -0.63% | ||
| 1 month | -4.58% | ||
| 3 months | -9.88% | ||
| 6 months | +5.65% | ||
| Current year | +0.62% |
| 1 week | 84.48 |  | 87.88 |
| 1 month | 83.81 | | 89.7 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/9/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/9/26 | Tax | Controller/Auditor | -253 | 0.0000% | ||
| 11/9/26 | Tax | Executive/Senior Manager | -398 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.81% | -2.61% | +12.04% | +16.39% | 49.85B | |
| +0.83% | -2.58% | +21.71% | +32.80% | 243B | |
| +1.34% | -3.37% | +3.20% | +0.58% | 152B | |
| +2.41% | +0.57% | -7.82% | +40.19% | 143B | |
| -1.45% | -5.24% | -57.00% | -20.22% | 61.14B | |
| -0.14% | -3.39% | +19.41% | +52.83% | 47.74B | |
| +1.29% | -0.23% | -20.20% | -18.72% | 47.74B | |
| -0.35% | +1.41% | -5.76% | +34.78% | 45.9B | |
| -2.11% | -1.56% | +165.06% | +91.23% | 41.3B | |
| -0.10% | -1.64% | +33.08% | +63.05% | 42.88B | |
| Average | +0.40% | -1.12% | +16.37% | +29.29% | 87.39B | |
| Weighted average by Cap. | +0.93% | -1.25% | +11.09% | +26.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.04B 5.64B 5.12B 9.64B 654B 9.72B 67.75B 26.47B 333B 25.39B 24.84B 1,070B | 7.43B 6.64B 6.2B 5.63B 10.6B 719B 10.68B 74.46B 29.09B 366B 27.91B 27.3B 1,176B |
| Net income | 1.44B 1.28B 1.2B 1.09B 2.05B 139B 2.06B 14.38B 5.62B 70.61B 5.39B 5.27B 227B | 1.9B 1.7B 1.58B 1.44B 2.71B 184B 2.73B 19.01B 7.43B 93.36B 7.12B 6.97B 300B |
| Net Debt | -3.63B -3.24B -3.03B -2.75B -5.18B -351B -5.22B -36.37B -14.21B -179B -13.63B -13.34B -574B | -5.19B -4.64B -4.33B -3.93B -7.41B -503B -7.46B -52.04B -20.33B -256B -19.5B -19.08B -822B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | USD 85.78 | -0.81% | 3,508,047 |
| 06/10/26 | USD 86.48 | -0.86% | 3,383,228 |
| 05/10/26 | USD 87.23 | +2.44% | 3,315,848 |
| 02/10/26 | USD 85.15 | -0.05% | 2,408,377 |
| 01/10/26 | USD 85.19 | -1.31% | 3,084,782 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
